scispace - formally typeset
F

Frank Petersen

Researcher at Novartis

Publications -  98
Citations -  6228

Frank Petersen is an academic researcher from Novartis. The author has contributed to research in topics: Chemokine & Platelet factor 4. The author has an hindex of 43, co-authored 98 publications receiving 5664 citations. Previous affiliations of Frank Petersen include University of Kiel & University of Göttingen.

Papers
More filters
Journal ArticleDOI

Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex

TL;DR: These compounds meet predicted criteria for disrupting Tcf/beta-catenin complexes and define a general standard to establish mechanism-based activity of small molecule inhibitors of this pathogenic protein-protein interaction.
Journal ArticleDOI

Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway.

TL;DR: A therapeutic window for pharmacological attenuation of HIF activity is demonstrated and the feasibility of disrupting a signal transduction pathway by targeting the function of a transcriptional coactivator with a small molecule is established.
Journal ArticleDOI

The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages

TL;DR: It is reported that the platelet-derived alpha-chemokine platelet factor 4 (PF4) induces the differentiation of monocytes into macrophages, as is evident from morphological changes as well as from the up-regulation of differentiation markers (carboxypeptidase M/MAX1 and CD71).
Journal ArticleDOI

Drug discovery from natural products

TL;DR: This review describes recent progress in drug discovery from natural sources including several examples of compounds that inhibit novel drug targets.